RECRUITING

Evaluation of Outcomes from Treatment of Benign or Malignant Gastroesophageal Diseases

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will be a retrospective chart review of patients who have been diagnosed with benign or malignant pancreatic disease under the practice of Dr. Rohan Jeyarajah, M.D., Dr. Houssam Osman M.D., and Dr. Edward Cho M.D., Sc.M. at Methodist Health System Hospital in Richardson, TX. The Investigators plan to conduct an analysis of patients meeting the inclusion criteria from 2005 to present. Study will also be conducted by the PI, Sub-Is, surgery fellows, office staff and clinical research coordinator who are delegated to do by the PI. Data will be obtained by looking through either the investigator's patients from their practice or through a national database. Data will be analyzed primarily by the study conductors.

Official Title

Evaluation of Outcomes from Treatment of Benign or Malignant Gastroesophageal Diseases

Quick Facts

Study Start:2019-03-06
Study Completion:2025-01-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04637256

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * All patients diagnosed and treated for gastroesophageal diseases, benign or malignant from 2005 to present.
  2. * Age ≥18 years
  1. * Patients that are not diagnosed with or treated for gastroesophageal diseases
  2. * Age \< 18 years

Contacts and Locations

Study Contact

Crystee Cooper, DHEd
CONTACT
214-947-1280
CrysteeCooper@mhd.com
Nitasha Phatak, Ph.D.
CONTACT
214-947-4459
NitashaPhatak@mhd.com

Principal Investigator

Dhiresh Jeyarajah, M.D.
PRINCIPAL_INVESTIGATOR
Methodist Health System

Study Locations (Sites)

Trinity Surgical Consultants, Methodist Richardson Medical Center
Richardson, Texas, 75082
United States

Collaborators and Investigators

Sponsor: Methodist Health System

  • Dhiresh Jeyarajah, M.D., PRINCIPAL_INVESTIGATOR, Methodist Health System

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2019-03-06
Study Completion Date2025-01-30

Study Record Updates

Study Start Date2019-03-06
Study Completion Date2025-01-30

Terms related to this study

Additional Relevant MeSH Terms

  • Pancreatic Malignant Neoplasm Primary